![REV 5901 adrine citrate 6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M22766_1635329797.gif?v=1635329798)
Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3
Smiles: C=CCNC1N=CN=C2C=CC(Br)=CC2=1
The activation of the M1 receptor by BQCA induces a robust inward current and increases spontaneous excitatory postsynaptic currents in medial prefrontal cortex (mPFC) pyramidal cells
InChi: InChI=1S/C31H48O3/c1-19(2)20(3)9-10-21(27(33)34)22-13-17-31(8)24-11-12-25-28(4
Imatinib also is an inhibitor of SARS-CoV and MERS-CoV
REV 5901 adrine citrate 6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3Ki: 0. 7 M for cysteinyl leukotriene receptor of guinea pig lung membranes REV 5901 is an antagonist of cysteinyl leukotriene receptors. Cysteinyl leukotriene receptor 1, a receptor for cysteinyl leukotrienes, contributes to mediating various allergic and hypersensitivity reactions by binding the cysteinyl LTs (CysLTs; viz, LTC4, LTD4, and to a much lesser extent, LTE4) in humans and models of the reactions in other animals. In vitro: Previous in
US$ 145.00
US$ 160.00
US$ 260.00
US$ 3205.00
US$ 167.50
US$ 1800.00